<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03127228</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00124386</org_study_id>
    <nct_id>NCT03127228</nct_id>
  </id_info>
  <brief_title>Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis</brief_title>
  <official_title>Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Morita J USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate if using Erbium-doped yttrium aluminium garnet laser,
      Erbium YAG laser (Er:YAG) laser could have adjunctive benefits to the conventional standard
      mechanical debridement to ablate the infected tissue around the dental implant and detoxify
      the contaminated implant surface for resolving peri-implant infection and enhance bone
      regeneration of peri-implant defects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to evaluate if using Er:YAG laser could have adjunctive benefits
      to the conventional standard mechanical debridement to ablate the infected tissue around the
      dental implant and detoxify the contaminated implant surface for resolving peri-implant
      infection and enhance bone regeneration of peri-implant defects.

      This study involves one center and a double-blinded randomized controlled clinical trial is
      planned. Twenty-four adult patients in the need of surgical treatment due to peri-implantitis
      will be included. Six visits are needed for each patient including a 24 week follow-up visit.

      Specific Aim 1: To compare the clinical benefit of Er:YAG laser-assisted peri-implant defect
      debridement and surface detoxification with conventional mechanical debridement for
      regenerative therapy

      Specific Aim 2: To evaluate whether Er:YAG laser-assisted regenerative surgical therapy can
      decrease bacterial load and alter microbial profile

      Specific Aim 3: To analyze whether Er:YAG laser-assisted regenerative surgical therapy can
      impact the molecular profile of the peri-implant crevicular fluid (PICF) and the stability of
      the treatment
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 26, 2017</start_date>
  <completion_date type="Actual">November 2, 2018</completion_date>
  <primary_completion_date type="Actual">November 2, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Periodontal Probing Depths (PD)</measure>
    <time_frame>Baseline and 24 Week</time_frame>
    <description>PD will be measured in millimeters. Change in PD measurements were calculated between baseline and 24 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Clinical Attachment Level (CAL)</measure>
    <time_frame>Baseline and 24 Week</time_frame>
    <description>CAL will be measured in millimeters. Change in subject CAL measurements were calculated between baseline and 24 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Bleeding on Probing (BOP)</measure>
    <time_frame>Baseline and 24 Week</time_frame>
    <description>BOP will be measured dichotomously as 0 or 1. Score 0=no bleeding present Score 1=bleeding present Change in subject BOP score was calculated between baseline and 24 weeks and reported as percent of sites with BOP.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Radiographic Bone Fill (RBF)</measure>
    <time_frame>Baseline and 24 Week</time_frame>
    <description>Peri-implant bony defect change will be measured compared to baseline. Participants' standardized radiographs were used to determine bone level changes between baseline and 24 weeks.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Peri-Implantitis</condition>
  <arm_group>
    <arm_group_label>Standard mechanical debridement</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Er:YAG laser-assisted debridement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard mechanical debridement</intervention_name>
    <description>Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
    <arm_group_label>Er:YAG laser-assisted debridement</arm_group_label>
    <arm_group_label>Standard mechanical debridement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Er:YAG laser-assisted debridement</intervention_name>
    <description>Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
    <arm_group_label>Er:YAG laser-assisted debridement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects, aged 18 - 85 years

          -  Physical status according to the American Society of Anesthesiologists (ASA) I or II,
             which includes patients who are systemically healthy or suffer under mild to moderate,
             but well controlled systemic diseases.

          -  Subjects having a minimum of 1 dental implant with peri-implantitis.

          -  Dental implants with peri-implantitis ≥ 2 threads exposed (infrabony defect)
             identified on the radiograph and pocket probing depth (PPD) ≥ 5mm, with bleeding on
             probing (BOP) and/or suppuration (pus)

          -  The implants are in function for at least 6 months

          -  Only rough surface implant will be included in this study

        Exclusion Criteria:

          -  Long-term use of antibiotics &gt; 2 weeks in the past two months

          -  Obvious malpositioning of the dental implants

          -  Subjects taking medications known to modify bone metabolism (such as bisphosphonates,
             corticosteroids, Hormone replacement therapy for menopausal women, parathyroid
             hormone, Denosumab, strontium ranelate)

          -  Pregnant females or those planning to become pregnant

          -  Subjects with a history of major diseases, oral cancer, sepsis or those having adverse
             outcomes to oral procedures in the past, will be excluded

          -  Mobility of dental implants

          -  History of alcoholism or drug abuse

          -  Current smokers

          -  Diseases of the immune system or any medical condition that may influence the outcome
             (uncontrolled diabetes (HbA1c &gt;8)

          -  Uncontrolled systemic disease or condition known to alter bone metabolism, like
             Osteoporosis, Osteopenia, Hyperparathyroidism, Paget's disease

        Premature Exclusion Criteria:

          -  The researcher believes that it is not the best interest of the subject to stay in the
             study

          -  If the subject becomes ineligible to participate based on the exclusion criteria

          -  If the subject's medical condition requires interventions which preclude involvement
             in the study (radiation therapy, chemotherapy, etc)

          -  If the subject does not follow study related instructions

          -  The study is suspended or canceled.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff (Chin-Wei) Wang, DDS, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Periodontics and Oral Medicine University of Michigan School of Dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan School of Dentistry</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aljateeli M, Fu JH, Wang HL. Managing peri-implant bone loss: current understanding. Clin Implant Dent Relat Res. 2012 May;14 Suppl 1:e109-18. doi: 10.1111/j.1708-8208.2011.00387.x. Epub 2011 Oct 10. Review.</citation>
    <PMID>21985674</PMID>
  </reference>
  <reference>
    <citation>Aoki A, Mizutani K, Schwarz F, Sculean A, Yukna RA, Takasaki AA, Romanos GE, Taniguchi Y, Sasaki KM, Zeredo JL, Koshy G, Coluzzi DJ, White JM, Abiko Y, Ishikawa I, Izumi Y. Periodontal and peri-implant wound healing following laser therapy. Periodontol 2000. 2015 Jun;68(1):217-69. doi: 10.1111/prd.12080.</citation>
    <PMID>25867988</PMID>
  </reference>
  <reference>
    <citation>Atieh MA, Alsabeeha NH, Faggion CM Jr, Duncan WJ. The frequency of peri-implant diseases: a systematic review and meta-analysis. J Periodontol. 2013 Nov;84(11):1586-98. doi: 10.1902/jop.2012.120592. Epub 2012 Dec 13. Review.</citation>
    <PMID>23237585</PMID>
  </reference>
  <reference>
    <citation>Claffey N, Clarke E, Polyzois I, Renvert S. Surgical treatment of peri-implantitis. J Clin Periodontol. 2008 Sep;35(8 Suppl):316-32. doi: 10.1111/j.1600-051X.2008.01277.x. Review.</citation>
    <PMID>18724859</PMID>
  </reference>
  <reference>
    <citation>De Bruyn H, Vandeweghe S, Ruyffelaert C, Cosyn J, Sennerby L. Radiographic evaluation of modern oral implants with emphasis on crestal bone level and relevance to peri-implant health. Periodontol 2000. 2013 Jun;62(1):256-70. doi: 10.1111/prd.12004. Review.</citation>
    <PMID>23574471</PMID>
  </reference>
  <reference>
    <citation>Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015 Apr;42 Suppl 16:S158-71. doi: 10.1111/jcpe.12334. Review.</citation>
    <PMID>25495683</PMID>
  </reference>
  <reference>
    <citation>Fransson C, Lekholm U, Jemt T, Berglundh T. Prevalence of subjects with progressive bone loss at implants. Clin Oral Implants Res. 2005 Aug;16(4):440-6.</citation>
    <PMID>16117768</PMID>
  </reference>
  <reference>
    <citation>Gonçalves F, Zanetti AL, Zanetti RV, Martelli FS, Avila-Campos MJ, Tomazinho LF, Granjeiro JM. Effectiveness of 980-mm diode and 1064-nm extra-long-pulse neodymium-doped yttrium aluminum garnet lasers in implant disinfection. Photomed Laser Surg. 2010 Apr;28(2):273-80. doi: 10.1089/pho.2009.2496.</citation>
    <PMID>19811080</PMID>
  </reference>
  <reference>
    <citation>Jensen MP, Karoly P, O'Riordan EF, Bland F Jr, Burns RS. The subjective experience of acute pain. An assessment of the utility of 10 indices. Clin J Pain. 1989 Jun;5(2):153-9.</citation>
    <PMID>2520397</PMID>
  </reference>
  <reference>
    <citation>Kinney JS, Morelli T, Oh M, Braun TM, Ramseier CA, Sugai JV, Giannobile WV. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol. 2014 Feb;41(2):113-120. doi: 10.1111/jcpe.12194. Epub 2013 Dec 12.</citation>
    <PMID>24303954</PMID>
  </reference>
  <reference>
    <citation>Kreisler M, Kohnen W, Marinello C, Götz H, Duschner H, Jansen B, d'Hoedt B. Bactericidal effect of the Er:YAG laser on dental implant surfaces: an in vitro study. J Periodontol. 2002 Nov;73(11):1292-8.</citation>
    <PMID>12479633</PMID>
  </reference>
  <reference>
    <citation>Marrone A, Lasserre J, Bercy P, Brecx MC. Prevalence and risk factors for peri-implant disease in Belgian adults. Clin Oral Implants Res. 2013 Aug;24(8):934-40. doi: 10.1111/j.1600-0501.2012.02476.x. Epub 2012 May 3.</citation>
    <PMID>22551347</PMID>
  </reference>
  <reference>
    <citation>Matys J, Dominiak M. Assessment of Pain When Uncovering Implants with Er:YAG Laser or Scalpel for Second Stage Surgery. Adv Clin Exp Med. 2016 Nov-Dec;25(6):1179-1184. doi: 10.17219/acem/62456.</citation>
    <PMID>28028971</PMID>
  </reference>
  <reference>
    <citation>Nevins M, Nevins ML, Yamamoto A, Yoshino T, Ono Y, Wang CW, Kim DM. Use of Er:YAG laser to decontaminate infected dental implant surface in preparation for reestablishment of bone-to-implant contact. Int J Periodontics Restorative Dent. 2014 Jul-Aug;34(4):461-6. doi: 10.11607/prd.2192.</citation>
    <PMID>25006763</PMID>
  </reference>
  <reference>
    <citation>Peri-implant mucositis and peri-implantitis: a current understanding of their diagnoses and clinical implications. J Periodontol. 2013 Apr;84(4):436-43. doi: 10.1902/jop.2013.134001. Review.</citation>
    <PMID>23537178</PMID>
  </reference>
  <reference>
    <citation>Quaranta A, Maida C, Scrascia A, Campus G, Quaranta M. Er:Yag Laser application on titanium implant surfaces contaminated by Porphyromonas gingivalis: an histomorphometric evaluation. Minerva Stomatol. 2009 Jul-Aug;58(7-8):317-30. English, Italian.</citation>
    <PMID>19633633</PMID>
  </reference>
  <reference>
    <citation>Renvert S, Roos-Jansåker AM, Claffey N. Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review. J Clin Periodontol. 2008 Sep;35(8 Suppl):305-15. doi: 10.1111/j.1600-051X.2008.01276.x. Review.</citation>
    <PMID>18724858</PMID>
  </reference>
  <reference>
    <citation>Schwarz F, Hegewald A, John G, Sahm N, Becker J. Four-year follow-up of combined surgical therapy of advanced peri-implantitis evaluating two methods of surface decontamination. J Clin Periodontol. 2013 Oct;40(10):962-7. doi: 10.1111/jcpe.12143. Epub 2013 Aug 12.</citation>
    <PMID>23931259</PMID>
  </reference>
  <reference>
    <citation>Schwarz F, Sahm N, Iglhaut G, Becker J. Impact of the method of surface debridement and decontamination on the clinical outcome following combined surgical therapy of peri-implantitis: a randomized controlled clinical study. J Clin Periodontol. 2011 Mar;38(3):276-84. doi: 10.1111/j.1600-051X.2010.01690.x. Epub 2011 Jan 11.</citation>
    <PMID>21219392</PMID>
  </reference>
  <reference>
    <citation>Suárez-López Del Amo F, Yu SH, Wang HL. Non-Surgical Therapy for Peri-Implant Diseases: a Systematic Review. J Oral Maxillofac Res. 2016 Sep 9;7(3):e13. eCollection 2016 Jul-Sep. Review.</citation>
    <PMID>27833738</PMID>
  </reference>
  <reference>
    <citation>Takasaki AA, Aoki A, Mizutani K, Kikuchi S, Oda S, Ishikawa I. Er:YAG laser therapy for peri-implant infection: a histological study. Lasers Med Sci. 2007 Sep;22(3):143-57. Epub 2007 Jan 12.</citation>
    <PMID>17219255</PMID>
  </reference>
  <reference>
    <citation>Wang HL, Garaicoa-Pazmino C, Collins A, Ong HS, Chudri R, Giannobile WV. Protein biomarkers and microbial profiles in peri-implantitis. Clin Oral Implants Res. 2016 Sep;27(9):1129-36. doi: 10.1111/clr.12708. Epub 2015 Oct 1.</citation>
    <PMID>26424287</PMID>
  </reference>
  <reference>
    <citation>Yamamoto A, Tanabe T. Treatment of peri-implantitis around TiUnite-surface implants using Er:YAG laser microexplosions. Int J Periodontics Restorative Dent. 2013 Jan-Feb;33(1):21-30.</citation>
    <PMID>23342343</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <results_first_submitted>October 12, 2019</results_first_submitted>
  <results_first_submitted_qc>October 12, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 1, 2019</results_first_posted>
  <last_update_submitted>October 31, 2019</last_update_submitted>
  <last_update_submitted_qc>October 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Chin-Wei Wang</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Laser</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT03127228/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Mechanical Debridement</title>
          <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
        </group>
        <group group_id="P2">
          <title>Er:YAG Laser-assisted Debridement</title>
          <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy
Er:YAG laser-assisted debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Mechanical Debridement</title>
          <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
        </group>
        <group group_id="B2">
          <title>Er:YAG Laser-assisted Debridement</title>
          <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy
Er:YAG laser-assisted debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.41" spread="13.48"/>
                    <measurement group_id="B2" value="66.41" spread="8.76"/>
                    <measurement group_id="B3" value="64.91" spread="11.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Periodontal Probing Depths (PD)</title>
        <description>PD will be measured in millimeters. Change in PD measurements were calculated between baseline and 24 weeks.</description>
        <time_frame>Baseline and 24 Week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Mechanical Debridement</title>
            <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
          </group>
          <group group_id="O2">
            <title>Er:YAG Laser-assisted Debridement</title>
            <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy
Er:YAG laser-assisted debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Periodontal Probing Depths (PD)</title>
          <description>PD will be measured in millimeters. Change in PD measurements were calculated between baseline and 24 weeks.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.85" spread="1.71"/>
                    <measurement group_id="O2" value="2.65" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Clinical Attachment Level (CAL)</title>
        <description>CAL will be measured in millimeters. Change in subject CAL measurements were calculated between baseline and 24 weeks.</description>
        <time_frame>Baseline and 24 Week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Mechanical Debridement</title>
            <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
          </group>
          <group group_id="O2">
            <title>Er:YAG Laser-assisted Debridement</title>
            <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy
Er:YAG laser-assisted debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Clinical Attachment Level (CAL)</title>
          <description>CAL will be measured in millimeters. Change in subject CAL measurements were calculated between baseline and 24 weeks.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.47" spread="1.76"/>
                    <measurement group_id="O2" value="1.90" spread="2.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Bleeding on Probing (BOP)</title>
        <description>BOP will be measured dichotomously as 0 or 1. Score 0=no bleeding present Score 1=bleeding present Change in subject BOP score was calculated between baseline and 24 weeks and reported as percent of sites with BOP.</description>
        <time_frame>Baseline and 24 Week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Mechanical Debridement</title>
            <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
          </group>
          <group group_id="O2">
            <title>Er:YAG Laser-assisted Debridement</title>
            <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy
Er:YAG laser-assisted debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bleeding on Probing (BOP)</title>
          <description>BOP will be measured dichotomously as 0 or 1. Score 0=no bleeding present Score 1=bleeding present Change in subject BOP score was calculated between baseline and 24 weeks and reported as percent of sites with BOP.</description>
          <units>percentage of sites with BOP</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.39" spread="0.55"/>
                    <measurement group_id="O2" value="-0.31" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Radiographic Bone Fill (RBF)</title>
        <description>Peri-implant bony defect change will be measured compared to baseline. Participants' standardized radiographs were used to determine bone level changes between baseline and 24 weeks.</description>
        <time_frame>Baseline and 24 Week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Mechanical Debridement</title>
            <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
          </group>
          <group group_id="O2">
            <title>Er:YAG Laser-assisted Debridement</title>
            <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy
Er:YAG laser-assisted debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Radiographic Bone Fill (RBF)</title>
          <description>Peri-implant bony defect change will be measured compared to baseline. Participants' standardized radiographs were used to determine bone level changes between baseline and 24 weeks.</description>
          <units>Millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.08" spread="1.04"/>
                    <measurement group_id="O2" value="1.27" spread="1.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>The methods for gathering adverse events included a medical and dental history review at each study visit and an oral exam at each study visit. In addition, participants self-reported any adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard Mechanical Debridement</title>
          <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
        </group>
        <group group_id="E2">
          <title>Er:YAG Laser-assisted Debridement</title>
          <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.
Standard mechanical debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy
Er:YAG laser-assisted debridement: Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ulcer on ear</sub_title>
                <description>During the oral exam it was noticed that the participant had an ulcer on his right ear. Participant was referred to this primary care physician for care.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Tooth pain</sub_title>
                <description>Participant reported tooth pain in lower right quadrant of his mouth. This was a non-study tooth. Participant was referred to his general dentist for care.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Jaw discomfort</sub_title>
                <description>Participant reported having jaw discomfort in both of his jaw joints. Participant was currently being treated by his general dentist.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Broken filling</sub_title>
                <description>Participant reported having a broken filling on a non-study tooth. Participant had an appointment scheduled with their general dentist for care.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Residual suture</sub_title>
                <description>Participant reported that there was a residual suture in his mouth. Suture was removed.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Crown off</sub_title>
                <description>Participant reported that the crown fell off of his tooth (non-study tooth). Participant was referred to general dentist for treatment.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Shingles</sub_title>
                <description>Participant reported that he had shingles and was being treated by his primary care physician.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Type 2 Diabetes</sub_title>
                <description>During medical/dental history review the participant reported to have recently been diagnosed with type 2 diabetes.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Flu</sub_title>
                <description>Participant reported having the flu and currently taking antibiotics.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <description>Participant reported having a &quot;water bubble&quot; on the inside of his lower left molar. Upon examination it was determined that the participant could have a root canal infection. Participant was referred to a root canal specialist for treatment.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Shoulder Pain</sub_title>
                <description>During medical and dental history update the participant reported to have fallen on her shoulder and went to see her primary care physician for treatment.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Sinus Tract Infection</sub_title>
                <description>During medical/dental history update participant reported having a sinus tract infection. Dispensed antibiotics and referred participant to their primary care physician.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Chin-Wei Wang</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734-763-2105</phone>
      <email>jeffwa@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

